Roflumilast and aquaporin‐2 regulation in rat renal inner medullary collecting duct

Roflumilast is a cyclic nucleotide phosphodiesterase inhibitor that is FDA‐approved for treatment of chronic obstructive pulmonary disease. With a view toward possible use for treatment of patients with X‐linked nephrogenic diabetes insipidus (NDI) due to hemizygous mutations in the V2 vasopressin r...

Descripción completa

Detalles Bibliográficos
Autores principales: Umejiego, Ezigbobiara N., Wang, Yanhua, Knepper, Mark A., Chou, Chung‐Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269416/
https://www.ncbi.nlm.nih.gov/pubmed/28108651
http://dx.doi.org/10.14814/phy2.13121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269416/
https://www.ncbi.nlm.nih.gov/pubmed/28108651
http://dx.doi.org/10.14814/phy2.13121

Ejemplares similares